Menu
Sign In Pricing Add Podcast
Podcast Image

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch

20Growth: Inside Perplexity's Growth Machine: What Worked, What Did Not Work | Why Paid Acquisition is a Drug and Brand Marketing is BS | The Good, Bad and Ugly of A/B Tests and Why Micro-Optimisations are Under-Rated with Raman Malik

Fri, 15 Nov 2024

Description

Raman Malik is the Head of Growth at Perplexity where he is responsible for growth marketing, onboarding, activation, retention, and monetisation. Prior to Perplexity, Raman, was an early member of the growth team at Lyft and joined Perplexity earlier this year after his own startup journey.  In Today’s Episode with Perplexity’s Head of Growth:  1. Inside the Perplexity Growth Machine: What have been the single biggest needle movers in the growth of Perplexity? What has not worked? What have they learned from that? How have partnerships driven growth? Lessons on what makes a good vs bad partnership? Why does Raman think paid acquisition is a drug and Perplexity do not do it? How does Raman advise other founders when it comes to paid acquisition? 2. Acquisition, Retention, Churn: Mastering the Basics: Why does Raman think that brand marketing is BS? When does it become more important? What are the simplest things startups and product teams can do to drive retention up? How do Perplexity count an “engaged user”? What metric suggests they have a retained user? What is the good, the bad and the ugly when it comes to A/B tests? 3. How Perplexity Built a Growth Machine: Why does Raman advise all founders to hire more former founders? How does the way you manage founders turned employees differ from employees who have never been founders? What is the must under appreciated growth channel today that has worked for Perplexity? What growth channel has been the biggest flop for Perplexity? What did Raman learn from losing money on the channel?

Audio
Featured in this Episode

No persons identified in this episode.

Transcription
Comments

There are no comments yet.

Please log in to write the first comment.